These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16920344)

  • 61. Chlorogenic acid is poorly absorbed, independently of the food matrix: A Caco-2 cells and rat chronic absorption study.
    Dupas C; Marsset Baglieri A; Ordonaud C; Tomé D; Maillard MN
    Mol Nutr Food Res; 2006 Nov; 50(11):1053-60. PubMed ID: 17054098
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration.
    Sezgin Z; Yuksel N; Baykara T
    Int J Pharm; 2007 Mar; 332(1-2):161-7. PubMed ID: 17055200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intestinal drug transport enhancement by Aloe vera.
    Chen W; Lu Z; Viljoen A; Hamman J
    Planta Med; 2009 May; 75(6):587-95. PubMed ID: 19214949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast.
    Abdel-Aziz H; Kelber O; Lorkowski G; Storr M
    Planta Med; 2017 Oct; 83(14-15):1130-1140. PubMed ID: 28859216
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate.
    Zgair A; Dawood Y; Ibrahem SM; Lee JB; Feng W; Fischer PM; Gershkovich P
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders : A noninterventional study with Iberogast®.
    Raedsch R; Vinson B; Ottillinger B; Holtmann G
    Wien Med Wochenschr; 2018 Mar; 168(3-4):89-98. PubMed ID: 28744774
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sac of everted intestine technic for study of intestinal absorption in vitro.
    WISEMAN G
    Methods Med Res; 1961; 9():287-92. PubMed ID: 14007674
    [No Abstract]   [Full Text] [Related]  

  • 68. Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine.
    Allam S; Krueger D; Demir IE; Ceyhan G; Zeller F; Schemann M
    Phytomedicine; 2015 Nov; 22(12):1063-70. PubMed ID: 26547528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors.
    Thumann TA; Pferschy-Wenzig E-M; Kumpitsch C; Duller S; Högenauer C; Kump P; Aziz-Kalbhenn H; Ammar RM; Rabini S; Moissl-Eichinger C; Bauer R
    Microbiol Spectr; 2024 Jun; 12(6):e0403123. PubMed ID: 38738925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oral Pharmacokinetics of Hydroxycinnamic Acids: An Updated Review.
    Veras KS; Fachel FNS; de Araújo BV; Teixeira HF; Koester LS
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559157
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.
    Michael S; Abdel-Aziz H; Weiser D; Müller CE; Kelber O; Nieber K
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):411-21. PubMed ID: 22160002
    [TBL] [Abstract][Full Text] [Related]  

  • 72. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
    Müller MH; Liu CY; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
    Phytomedicine; 2006; 13 Suppl 5():100-6. PubMed ID: 16713220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components.
    Kelber O; Wittwer A; Lapke C; Kroll U; Weiser D; Okpanyi SN; Heilmann J
    Phytomedicine; 2006; 13 Suppl 5():107-13. PubMed ID: 16920344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.
    Simmen U; Kelber O; Okpanyi SN; Jaeggi R; Bueter B; Weiser D
    Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The active components and the pharmacological multi-target principle of STW 5 (Iberogast).
    Wegener T; Wagner H
    Phytomedicine; 2006; 13 Suppl 5():20-35. PubMed ID: 16926095
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.
    Ammon HP; Kelber O; Okpanyi SN
    Phytomedicine; 2006; 13 Suppl 5():67-74. PubMed ID: 16978852
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.